Mifisac-200 is a potent prescription-only medication containing 200 mg of Mifepristone, specifically formulated for precise gynecological applications under strict medical supervision. Supplied as a single uncoated tablet per pack, Mifisac-200 is designed to meet regulatory and therapeutic standards, ensuring safety, efficacy, and quality. Manufactured by Shree Venkatesh International Limited and marketed by SACRED LEAVES PRIVATE LIMITED, this medicine requires a registered medical practitioner’s supervision for use, aligning with all applicable laws and guidelines. Its packaging guarantees product integrity by protecting the tablet from environmental factors such as moisture and light. Mifisac-200 is ideally suited for clinical settings where controlled administration of Mifepristone 200 mg is essential for targeted gynecological treatment protocols, reinforcing the necessity of bespoke dosage and strict adherence to physician instructions.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Mifepristone 200 mg |
| Dosage Form | Uncoated Tablet |
| Prescription Requirement | Mandatory prescription only |
| Packaging | 1 tablet per box, sealed for quality and safety |
| Intended Use | Gynecological treatments under medical supervision |
| Manufacturer | Shree Venkatesh International Limited, India |
| Marketer | SACRED LEAVES PRIVATE LIMITED, New Delhi, India |
| Storage Conditions | Store below 25°C, protect from light |
| Country of Origin | India |
| Attributes | Description |
|---|---|
| Composition | Each uncoated tablet contains 200 mg of Mifepristone and excipients q.s. |
| Form | Tablet |
| Quantity per Pack | 1 uncoated tablet |
| Prescription Status | Prescription-only medicine |
| Storage Temperature | Below 25°C |
| Packaging Type | Sealed box for protection |
| Manufacturer Location | India |
| Marketing Location | India |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Mifisac-200 is a prescription-only medicine and must be used strictly under the supervision of a registered medical practitioner.
Mifisac-200 should be stored below 25°C and protected from exposure to light to preserve its stability and potency.
Each Mifisac-200 tablet contains 200 mg of the active ingredient Mifepristone.
Mifisac-200 is manufactured by Shree Venkatesh International Limited and marketed by SACRED LEAVES PRIVATE LIMITED, New Delhi, India.
No, Mifisac-200 must not be self-administered and requires administration only under medical guidance.
Mifisac-200 is packaged as a single uncoated tablet per box, sealed to ensure product quality and safety.
Brand: sacred leaves
Country Of Origin: India
Mifisac-200 is a prescription-only medicine containing Mifepristone 200 mg, intended for use under the strict supervision of a registered medical practitioner in accordance with applicable laws. It is indicated for specific gynecological purposes as directed by a physician.
Each pack contains 1 uncoated tablet, securely packaged to maintain product integrity and quality. This product should only be prescribed, dispensed, and consumed under medical guidance.
Key Features & Specifications:
Active Ingredient: Mifepristone 200 mg
Composition
Each uncoated tablet contains:
Dosage & Usage:
To be used strictly as directed by the physician.
Packaging:
Each box contains 1 uncoated tablet, sealed to ensure quality and safety.
Important Notes:
Inclusive of all taxes
You Save: 0
South West Delhi , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Wholesaler
GST- 07abdcs0098k1z2
